CDMO Joinn Biologics snaps up China biologics plant from Lonza in push to tackle Asia-Pacific market
With the purchase of a former Lonza biologics plant now in the books, San Francisco-based CDMO Joinn Biologics is expanding from one Bay Area to another. Over the weekend, Joinn announced (Chinese ...
Jan. 22, 2025 /PRNewswire/ -- ImaginAb, Inc., announces that it has entered into an agreement to sell a pipeline of next-generation therapeutic candidates, proprietary novel biologics technology ...
Samsung Biologics closed 2024 on several high notes, reaching its highest annual revenue to date — and just a week ago, securing its largest client contract … ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results